FdaApplication
NDA 206040
Identifiers
- fda_app_no: NDA206040
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABS LTD |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ | LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ | 150MG;300MG;600MG | TABLET;ORAL |
1 product